These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36699148)

  • 1. The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients.
    Louw E; Baines N; Maarman G; Osman M; Sigwadhi L; Irusen E; Koegelenberg C; Doubell A; Nathan S; Channick R; Allwood B
    Pulm Circ; 2023 Jan; 13(1):e12184. PubMed ID: 36699148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in adults completing tuberculosis treatment.
    Allwood BW; Manie S; Stolbrink M; Hunter L; Matthee S; Meintjes G; Amosun SL; Pecoraro A; Walzl G; Irusen E
    Afr J Thorac Crit Care Med; 2023; 29(3):. PubMed ID: 37970573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters.
    Papakosta D; Pitsiou G; Daniil Z; Dimadi M; Stagaki E; Rapti A; Antoniou K; Tzouvelekis A; Kontakiotis T; Tryfon S; Polychronopoulos V; Bouros D
    Lung; 2011 Oct; 189(5):391-9. PubMed ID: 21660584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of pulmonary hypertension in post-tuberculosis and active tuberculosis populations: a systematic review and meta-analysis.
    van Heerden JK; Louw EH; Thienemann F; Engel ME; Allwood BW
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38232991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic estimation of pulmonary arterial systolic pressure in acute heart failure. Prognostic implications.
    Merlos P; Núñez J; Sanchis J; Miñana G; Palau P; Bodí V; Husser O; Santas E; Bondanza L; Chorro FJ
    Eur J Intern Med; 2013 Sep; 24(6):562-7. PubMed ID: 23684500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of the hemodynamics of pulmonary artery and right ventricular function in chronic obstructive pulmonary disease with pulmonary hypertension using cardiac magnetic resonance imaging].
    Fan Y; Guo X; Sun X; Cao X; He J; Zhu L; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):972-977. PubMed ID: 31537222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
    Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follow-up study of patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension].
    Wang RR; Wang TS; Su XL; Mao YM; Sun YX; Qu HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2021 Aug; 44(8):717-722. PubMed ID: 34645138
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary hypertension in patients with chronic obstructive pulmonary disease: clinical characteristics and risk factors].
    Wang T; Mao Y; Sun Y; Hou W; Feng Y; Qu H
    Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1037-40. PubMed ID: 26887371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
    Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
    Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.
    Lam CS; Roger VL; Rodeheffer RJ; Borlaug BA; Enders FT; Redfield MM
    J Am Coll Cardiol; 2009 Mar; 53(13):1119-26. PubMed ID: 19324256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired 6-min walk test, heart rate recovery and cardiac function post pulmonary embolism in long-term survivors.
    Chow V; Ng AC; Seccombe L; Chung T; Thomas L; Celermajer DS; Peters M; Kritharides L
    Respir Med; 2014 Oct; 108(10):1556-65. PubMed ID: 25154698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult pulmonary arterial hypertension in patients with previous pulmonary tuberculosis.
    Kalla IS; Miri A; Seedat F
    Afr J Thorac Crit Care Med; 2020; 26(4):. PubMed ID: 34240037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.
    Alushi B; Beckhoff F; Leistner D; Franz M; Reinthaler M; Stähli BE; Morguet A; Figulla HR; Doenst T; Maisano F; Falk V; Landmesser U; Lauten A
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):591-601. PubMed ID: 29680341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases].
    Liu XQ; Yan H; Qiu JX; Zhang CY; Qi JG; Zhang X; Xiao HJ; Yang YL; Chen YH; Du JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):768-777. PubMed ID: 29045954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Pulmonary Hypertension With End-Stage Renal Disease Among the Obese Population.
    Jameel FA; Junejo AM; Ejaz A; Khan QUA; Bhopal KF; Faraz A; Rizvi SHM; Ahmad F; Tahir M
    Cureus; 2020 Aug; 12(8):e9722. PubMed ID: 32944441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function and diffusion capacity are associated with pulmonary arterial systolic pressure in the general population: The Rotterdam Study.
    Loth DW; Lahousse L; Leening MJG; Krijthe BP; Felix JF; Gall H; Hofman A; Ghofrani HA; Franco OH; Stricker BH; Brusselle GG
    Respir Med; 2017 Nov; 132():50-55. PubMed ID: 29229105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden and determinants of post-TB lung disease.
    Mpagama SG; Msaji KS; Kaswaga O; Zurba LJ; Mbelele PM; Allwood BW; Ngungwa BS; Kisonga RM; Lesosky M; Rylance J; Mortimer K
    Int J Tuberc Lung Dis; 2021 Oct; 25(10):846-853. PubMed ID: 34615582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study.
    Chin AT; Rylance J; Makumbirofa S; Meffert S; Vu T; Clayton J; Mason P; Woodruff P; Metcalfe J
    Int J Tuberc Lung Dis; 2019 Feb; 23(2):203-211. PubMed ID: 30808453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.